Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
Vision and vision-related outcome measures in multiple sclerosis.
The Chalder Fatigue Questionnaire is a valid and reliable measure of perceived fatigue severity in multiple sclerosis.
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Nutritional factors and aging in demyelinating diseases.
Longitudinal assessment of clinically isolated syndrome with diffusion tensor imaging and volumetric MRI.
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
Molecular analysis of polimorphisms in HLA-CLASS II DRB1* and IL7Rα possibly associated with multiple sclerosis susceptibility in a population sample of Rio de Janeiro.
[Clinico-radiological profile of acute disseminated encephalomyelitis in the childhood population. A retrospective analysis of a series of 20 patients in a tertiary hospital].
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients.
Onset of neuromyelitis optica in the elderly.
Depression during multiple sclerosis relapse: relation to disability and relapse severity.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Stimulation of monocytes, macrophages, and microglia by amphotericin B and macrophage colony-stimulating factor promotes remyelination.
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis.
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study.
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.
Interventions for children coping with parental multiple sclerosis: A systematic review.
Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Multiple sclerosis and pregnancy prescriptions.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Pages
« first
‹ previous
…
571
572
573
574
575
576
577
578
579
…
next ›
last »